PDCD1 and ovarian carcinoma: Similarly, another study found that the expression of multiple immune checkpoints was upregulated in tumor-associated lymphocytes (TALs) isolated from patients with ovarian cancer, and the co-expression of PD-1 and LAG-3 was the most significant in CD8+ TALs, similar to the findings observed in mouse model 90.